GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hester Biosciences Ltd (BOM:524669) » Definitions » Tax Expense

Hester Biosciences (BOM:524669) Tax Expense : ₹120 Mil (TTM As of Dec. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Hester Biosciences Tax Expense?

Hester Biosciences's tax expense for the months ended in Dec. 2024 was ₹20 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹120 Mil.


Hester Biosciences Tax Expense Historical Data

The historical data trend for Hester Biosciences's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hester Biosciences Tax Expense Chart

Hester Biosciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.24 154.05 140.18 121.19 107.87

Hester Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.91 34.72 31.06 34.77 19.58

Hester Biosciences Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹120 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hester Biosciences  (BOM:524669) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Hester Biosciences Tax Expense Related Terms

Thank you for viewing the detailed overview of Hester Biosciences's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Hester Biosciences Business Description

Traded in Other Exchanges
Address
Motilal Hirabhai Road, Pushpak, 1st Floor, Panchvati Circle, Ahmedabad, GJ, IND, 380006
Hester Biosciences Ltd is an India based animal healthcare company. The company's operating segment includes Poultry Healthcare, Animal Healthcare, Petcare and Others. It generates maximum revenue from the Poultry Healthcare segment. The company's products are used to cure poultry diseases such as Fowl Pox, Newcastle Disease, Infectious Bronchitis and others. Geographically, it sells the products in India and also exports them to other countries, of which key revenue is derived from India.

Hester Biosciences Headlines

No Headlines